CYTOS
Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.
CYTOS
Industry:
Biotechnology Hospital Pharmaceutical
Founded:
1995-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.cytos.com
Total Employee:
51+
Status:
Active
Contact:
4117334644
Email Addresses:
[email protected]
Total Funding:
125.57 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS 1and1
Similar Organizations
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Triskel Biopharmaceuticals AG
Triskel Biopharmaceuticals AG is specialised in the development of late stage and clearly differentiated biotechnology drugs
Founder
Stock Details
Investors List
Amgen Ventures
Amgen Ventures investment in Post-IPO Equity - Cytos
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Cytos
Abingworth
Abingworth investment in Post-IPO Equity - Cytos
venBio Partners
venBio Partners investment in Post-IPO Equity - Cytos
Alta Partners
Alta Partners investment in Series B - Cytos
HealthCap
HealthCap investment in Series B - Cytos
Novartis
Novartis investment in Series B - Cytos
Aventic Partners AG
Aventic Partners AG investment in Series B - Cytos
New Medical Technologies
New Medical Technologies investment in Series B - Cytos
Lombard Odier
Lombard Odier investment in Series B - Cytos
Official Site Inspections
http://www.cytos.com
- Host name: decimus.sui-inter.net
- IP address: 80.74.142.130
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
